Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Conjugated Linoleic Acid (CLA)
Sponsor: Dartmouth-Hitchcock Medical Center
Collaborators: Dartmouth College